Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Restored can worsen aged skin by removing recoverable living cells

In , restoring may remove living cells needed for repair. Protecting recoverable must restore through repeated challenges while leaving unchanged, and protected cells must survive and produce .

Omega Point 1.2

Stage of verification

  1. Hypothesis published2026-09-21
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

Macrophage recognition and engulfment of apoptotic cells in skin, with discrimination between these targets and stressed but recoverable basal keratinocytes needed for barrier resealing.Selective apoptotic cell clearance

Direction

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Lens
Phagocytic target discrimination
Goal
Damage–Repair Reinforcement and Post-Injury Persistence Suppression
Competing hypotheses
2
Published
2026-09-21
Engine version
Omega Point 1.2
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Lipid

    A molecule whose exposure on cells is involved in their recognition for

    Where this hypothesis actsRecoverable in aged skin during repeated

    Hypotheses on this target 1
    PhosphatidylserineLower level. Hypotheses on this target 0Neutralisation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Composition restoration. Hypotheses on this target 0
    • Lower level
    • Neutralisation
    • Supplementation
    • Composition restoration

    What is proposed

    Suppress reversible exposure on

    With whatNot stated in the record

    How suppression of exposure, with validation that genuine -cell disposal remains intact; the specific intervention is not stated

    Possible result

    Possible preservation of recoverable and restoration of after repeated

    From the recordKeratinocyte-restricted suppression of reversible phosphatidylserine exposure prevents this loss and restores repeated-challenge sealing while labelled apoptotic-neutrophil clearance remains unchanged.

  2. Receptor or channel

    A protein involved in clearance of cell corpses

    Where this hypothesis acts in aged skin during repeated mild

    Hypotheses on this target 2
    TIM-4Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Blockade. Hypotheses on this target 0Agonism. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function restoration. Hypotheses on this target 11Function preservation. Hypotheses on this target 0
    • Lower level
    • Higher level
    • Blockade
    • Agonism
    • Desensitisation
    • Function restoration1
    • Function preservation

    What is proposed

    Function restoration

    Restore activity

    With whatNot stated in the record

    How manipulation; the precise restoration method is not stated

    Possible result

    Expected increase in of recoverable despite normal -

    From the recordRestoring TIM-4-dependent corpse clearance in aged skin increases collateral engulfment of stressed but recoverable basal keratinocytes.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Platelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTPhosphatidylserine. Hypotheses on this target 1Phosphatidylserine
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT112-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαTIM-4. Hypotheses on this target 2TIM-4
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Aging skin may struggle to stay sealed because repair repeatedly loses the cells it needs. The unexpected move is that improving dead-cell removal could worsen this loss by making living, recoverable cells targets for removal. That is a proposal generated by the pipeline, not a measured result in aged skin.

The proposed mechanism, link by link
  1. Repeated mild are proposed to expose on recoverable .
  2. Inflammatory signals from aged supporting tissue would change that exposure from transient to prolonged.
  3. Restored activity would make engulf these recoverable cells alongside genuine corpses.
  4. would remove living cells needed to reseal the skin, despite normal .
  5. Repeated loss of repair cells would sustain barrier leakage and downstream damage to the surrounding structural material.
  6. Selective protection of recoverable cells is predicted to restore without reducing genuine .
A picture for it

A cleanup crew removes anything carrying a disposal sticker. Making the crew faster causes harm if usable items temporarily carry the same sticker as rubbish.

Where the picture breaks: Cells do not carry a simple yes-or-no label: the proposal depends on a reversible surface change and whether the marked cells can actually recover. The picture does not establish how distinguishes targets or whether this mistake occurs in aged skin.

  1. Master questionstep 01 of 04

    Aging human skin might reach and maintain a youthful functional state through a sufficient combination of changes in its cells, surrounding structural material, stem-cell support sites, blood vessels and nerves.

    Rests on: The goal itself is to identify the smallest combination of changes that could produce and maintain that state; it does not establish that such a combination exists.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Lasting recovery requires addressing damage and repair processes that reinforce one another, including harmful effects that persist after injury.

    Rests on: The master question explicitly requires maintaining improved function, which supplies the basis for examining persistent damage after injury.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Restoring corpse removal by , immune cells that engulf cellular material, might stop recurring damage between the skin's protective barrier and its , the structural material surrounding cells. Alternatively, aged , the tissue environment supporting those cells, might restart the damage during repeated mild .

    Rests on: The preceding stage identifies persistent damage as a target but does not identify corpse removal or aged supporting tissue as the process responsible.

    Leap

    The chain does not supply the bridge from persistent post-injury damage to a feedback loop specifically maintained by deficient or aged supporting tissue. The screened sources do not establish that loop in aged skin.

  4. Hypothesisstep 04 of 04

    Restoring the corpse-recognition receptor called , whose full name is not supplied, is proposed to increase removal of stressed but recoverable , cells in the skin's deepest outer-layer compartment. Repeated challenges would expose , a cell-membrane component whose outward exposure can signal removal, while inflammatory signals from aged supporting tissue would prolong that exposure. Losing these living repair cells would sustain leakage and damage even when actual corpses are cleared normally.S4S6

    Rests on: The gap question supplies the setting of recurring damage despite normalized clearance. A 2016 Journal of Cell Science study reports that engulfed cells were still alive and survived when was blocked, but does not establish this mechanism in aged skin or its dependence on . A 2020 Frontiers in Immunology source describes reversible exposure on cells, but concerns a rat brain-injury setting rather than the proposed skin mechanism.

    Supported by literature

What is carried, and what is not. Three components have screened support or background: receptor recognition, removal of recoverable living cells, and reversible surface marking. S3, in Frontiers in Immunology in 2022, describes as a receptor involved in corpse but does not examine the proposed aged-skin effects; S4 and S6 supply the other components in different systems, and nothing establishes the sequence end to end. The 2023 mouse-wound account supplied as S2, a bioRxiv preprint with the same title as the eLife record S1, reports impaired clearance and wound repair when the receptor is inhibited; this points toward a repair benefit in that setting but does not settle restoration in aged skin.S3S4S6S2S1

Where the reasoning is carried by something unstated · 1
  • Gap question. The chain does not supply the bridge from persistent post-injury damage to a feedback loop specifically maintained by deficient or aged supporting tissue. The screened sources do not establish that loop in aged skin. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • of cells with intact outer membranes could be mistaken for removal of recoverable cells when those cells were already irreversibly dying. What closes it: The specified cell tracking must establish before irreversible death, and protected cells must subsequently survive and produce specialized descendant cells. Absence of detected alone is insufficient.
  • Better after suppression of exposure could be credited to preventing even if the intervention directly improves how skin cells mature and build the barrier. What closes it: The proposed intervention requires validation that it does not directly improve barrier-cell maturation. Reduced live-cell and later survival must accompany improved , while clearance of labelled corpses, dead cells from another immune-cell type, remains unchanged.
  • Failure of protection to improve could be read as rejection of the mechanism even if the intervention never selectively prevented the proposed live-cell removal. What closes it: A negative result requires verified suppression of the targeted surface exposure and live-cell , with genuine corpse disposal preserved. The supplied design explicitly leaves validation of that selectivity outstanding.

What would make this wrong. The mechanism would be rejected if verified restoration produced no of recoverable living skin cells, or if verified selective prevention of that failed to prevent recurring leakage while genuine remained normal. Prevention of recurrence by interventions against the rival extracellular signals or -fragment process would further favor those explanations.

What it would change. If the prediction held, restoring skin function would require distinguishing recoverable cells from corpses, rather than treating faster corpse removal as sufficient repair. That would add a specific requirement to the master question's search for a minimal set of lasting changes. Results in , laboratory tissue models organized to resemble skin, would still not establish stable rejuvenation in aging humans or exclude the competing explanations involving persistent inflammatory signals and self-renewing fragments. The supplied material does not define , the state measure the hypothesis predicts will stabilize.

Sources read · 6

4 literature searches, 6 full texts; 6 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Contradicts it

Apoptosis recognition receptors regulate skin tissue repair in mice. · eLife · 2023

“Taken together, these results indicate that Timd4 activity is required for reducing apoptotic cells, inflammation gene expression, and revascularization after injury.”

Does not settle: This mouse wound study does not examine aged skin, restoration of TIM-4 activity, phosphatidylserine exposure on viable basal keratinocytes, collateral engulfment, barrier leakage, matrix damage, or SPV_1.

S2Contradicts it

Apoptosis recognition receptors regulate skin tissue repair in mice. · bioRxiv : the preprint server for biology · 2023

“By contrast, inhibition of another efferocytosis receptor, Timd4, in mouse wounds decreases efferocytosis and abrogates wound repair.”

Does not settle: This mouse-wound study does not establish effects in aged skin, collateral engulfment of recoverable basal keratinocytes, phosphatidylserine exposure on living cells, stromal inflammatory prolongation, barrier leakage, matrix damage, or SPV_1.

S3Background

Autofluorescence identifies highly phagocytic tissue-resident macrophages in mouse and human skin and cutaneous squamous cell carcinoma. · Frontiers in immunology · 2022

“This is highly possible for the TIM-4 + AF + macrophage subset identified in mouse skin corresponding to a subset skin-resident macrophages, as TIM-4 is known as a phosphatidyl serine receptor involved in the phagocytosis of apoptotic cells ( ).”

Does not settle: It does not examine aged skin, barrier challenges, phosphatidylserine exposure on viable keratinocytes, collateral engulfment, barrier repair, matrix damage, or selective protection of viable targets.

S4Partly answers it

Activated microglia cause reversible apoptosis of pheochromocytoma cells, inducing their cell death by phagocytosis. · Journal of cell science · 2016

“The PC12 cells were not dead at the time they were phagocytised, and inhibition of their phagocytosis left viable cells.”

Does not settle: This source does not establish TIM-4 dependence, aged skin, basal keratinocytes, barrier challenges, stromal inflammatory signals, apoptotic-corpse clearance, barrier leakage, matrix damage, or SPV_1.

S5Background

Two alternative mechanisms that regulate the presentation of apoptotic cell engulfment signal in Caenorhabditis elegans. · Molecular biology of the cell · 2007

“Phosphatidylserine exposed on the surface of apoptotic mammalian cells is considered an “eat-me” signal that attracts phagocytes.”

Does not settle: This source does not establish effects in aged skin, TIM-4-dependent clearance, basal keratinocytes, reversible phosphatidylserine exposure on living cells, barrier repair, matrix damage, or selective protection of viable targets.

S6Partly answers it

TMEM16F Aggravates Neuronal Loss by Mediating Microglial Phagocytosis of Neurons in a Rat Experimental Cerebral Ischemia and Reperfusion Model. · Frontiers in immunology · 2020

“Studies have shown that PS-exposure not only occurs on the surface of cells as an early sign of cell death, but that it can also occur on the surface of viable cells in a reversible manner.”

Does not settle: This source concerns neurons and microglia in rat cerebral ischemia/reperfusion, not aged skin, basal keratinocytes, TIM-4-dependent macrophage clearance, barrier challenges, stromal inflammatory signals, barrier resealing, matrix damage, or SPV_1. It does not establish that restoring corpse clearance causes the proposed skin effects.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Does restored dead-cell removal stop skin damage after repeated challenges, or can aged surrounding tissue restart it?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Does restoring terminate , or does aged reinstate it despite normalized clearance during repeated mild ?

What this question is asking

The question concerns whether restoring dead-cell removal can produce lasting recovery in aging human skin. It asks whether , immune cells that clear dead cells, can interrupt a proposed cycle in which damage to the skin’s protective barrier and its supporting material reinforces further damage. The competing possibility is that aged , the surrounding support cells and material, restarts this cycle even while dead-cell removal remains normal during repeated mild challenges to the barrier. The intended comparison is lasting recovery versus returning damage, measured through barrier , inflammation, and the arrangement of supporting material relative to young skin, ultimately over twenty years. The question assumes that this reinforcing cycle exists and that surrounding aged tissue might sustain it independently of defective clearance; the supplied sources do not establish that complete mechanism.

What the terms mean
Macrophage
An immune cell that can engulf dead cells and release signals affecting inflammation and repair. can adopt overlapping patterns of activity; repair-associated activity is not a guarantee of normal tissue restoration.
Corpse clearance or dead-cell clearance
Removal of dead cells by other cells, including . Restoring deficient clearance means bringing impaired removal back toward a reference level; increasing clearance does not by itself establish that this has happened.
Skin barrier and barrier sealing
The skin’s protective boundary and the restoration of its ability to separate the body from the outside environment. The supplied input does not specify how successful is measured.
Barrier challenge
An event that stresses or disrupts the skin’s protective boundary. The question specifies repeated mild challenges but supplies no method, strength, or interval.
Stroma or supporting tissue
The support cells and surrounding structural material within tissue. Aged is an age-related tissue context, not one uniform cell type or a single established mechanism.
Extracellular matrix
Material outside and between cells that provides structural support. Its organization concerns how that material is arranged, which can differ between repaired tissue and a scar.
Barrier–matrix damage reinforcement
The proposed cycle in which barrier damage and disruption of supporting material help perpetuate one another, with inflammation connecting the steps. The supplied sources do not establish this complete cycle.
Inflammation and resolution
Inflammation is an immune response to injury or disturbance; resolution is the process by which that response subsides. Reduced inflammation does not by itself demonstrate restored tissue organization or lasting recovery.
Neutrophil
A type of immune cell involved in the wound response. The supplied sources discuss both its removal by and its persistence in aged wounds.
Fibroblast
A support cell that helps produce and maintain . Fibroblasts are recipients of the altered communication described in S7.
Collagen
A structural protein in . S4 reports more orderly collagen rebuilding, an outcome distinct from wound closure alone.
Scar formation
Repair that leaves altered supporting tissue rather than fully restoring the preceding tissue organization. S3 shows that increased dead-cell clearance can accompany this outcome.
Normal clearance and youthful recovery time ranges
Comparison standards for how effectively dead cells are removed and how quickly young skin recovers. The pipeline requires these standards but supplies no numerical definitions or measurement procedures.
What the question takes for granted
Premise only partly supported
is a controllable contributor to a self-reinforcing , and aged may sustain or reinstate that loop independently of clearance.

are immune cells that remove dead cells, while the skin barrier protects the body and the surrounding support cells and material help maintain tissue structure. The assumption is that damage to these parts feeds back on itself, with aged support tissue potentially keeping that process going even after dead-cell removal is restored. If established, this would make continued clearance and continuing tissue damage separable explanations for whether recovery lasts.

The sources support narrower components: increased dead-cell clearance accompanies repair-supporting changes in S1, support cells influence inflammation and produce structural material in S5, and aged wounds show persistent inflammatory cells and altered communication with support cells in S7. These findings do not establish a self-reinforcing barrier– loop or show aged restarting it after clearance is normalized. The supplied material also does not substantiate the gap detail’s specific assertion that existing clearance evidence establishes . Failure to establish these claims in the supplied sources does not show that they are false.S1S5S7

The same question asked without the part nothing read establishes:

  • After dead-cell removal is restored in aging skin, do barrier , inflammation, and supporting-tissue organization remain recovered through repeated mild ?
  • When dead-cell removal remains normal during repeated mild skin challenges, does recovery differ between aged and young surrounding support tissue?
What turns on the answer
  • Recovery persists while clearance stays normal Under the proposed mechanism, removing dead cells would interrupt enough of the inflammation-and-damage sequence for barrier and supporting-tissue organization to recover repeatedly. If recovery continued within the time ranges seen in young skin, without progressively easier recurrence, clearance restoration would have met those functional criteria over the observed period. This would not by itself establish that every feature of skin aging had reversed.
  • Damage returns despite normal clearance Normal dead-cell removal would coexist with renewed barrier failure, inflammation, or disordered supporting material, showing that clearance restoration was insufficient for lasting recovery. Aged surrounding tissue would be a possible explanation within the question’s proposed mechanism, but recurrence alone would not establish that tissue as the cause.
  • Clearance deteriorates and damage returns The intervention would have failed to maintain the condition needed to distinguish the two main alternatives. Returning damage could still depend on defective dead-cell removal, so this outcome would not establish that aged surrounding tissue restarts damage independently of clearance.
Why it matters

In the proposed cycle, failure of the protective barrier contributes to inflammation, inflammation disrupts supporting tissue, and that disruption makes barrier recovery harder. Removing dead cells could interrupt a contributing source of inflammation, allowing recovery to continue. However, the supplied sources associate increased clearance with both repair-supporting changes and scar formation, so improved clearance alone cannot establish recovery of normal tissue organization [S1, S3]. If surrounding aged tissue restarts damage despite continued clearance, treating clearance as sufficient would mistake an early improvement for a lasting change. Conversely, lasting recovery through repeated challenges would support the narrower conclusion that continuing aged-tissue effects did not restart the measured damage under those conditions.

What is already established

evidence supports at RL-2; is RL-1, without integrated repeated-challenge restoration.

What would have to be true

, inflammation, and organization recover within , without increasing persistence or falling across repeated challenges and twenty-year follow-up.

What is missing

Whether restored clearance survives aged is unknown; cannot establish durable interruption of the .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Restoring -dependent in aged skin increases collateral of stressed but recoverable . Repeated transiently expose on these living cells; aged stromal inflammatory signals prolong that exposure. consequently remove cells needed for even while genuine - remains normal. Recurrent cell loss sustains barrier leakage and downstream damage. The causal defect is discrimination between recoverable cells and corpses, rather than insufficient clearance. Selectively protecting targets should stabilize .

What a later run added

A later run reached the same claim about the same subject. Its version was withdrawn in favour of this earlier one, and what it added is kept here, quoted exactly.

A step in the mechanism

Предполагается, что сублетальное повреждение временно выводит фосфатидилсерин на наружную поверхность кератиноцитов, а TRPV4-зависимая активность макрофагов превращает эту обратимую метку в необратимую потерю клеток.

Adds TRPV4-dependent macrophage activity as an execution step downstream of the phosphatidylserine signal.

A step in the mechanism

Механизм возможен только там, где микроповреждение обеспечивает физический контакт макрофага с кератиноцитом.

Adds microdamage-mediated physical access as an explicit condition for the mechanism.

A sharper prediction

В модели кожи с сенсорными нейронами и макрофагами отсроченное подавление TRPV4 уменьшит вторичную потерю кератиноцитов сильнее блокады IL-31 при сопоставимом подавлении ответа на зудовые стимулы и одинаковой механической нагрузке. Макрофагоспецифическое выключение TRPV4 воспроизведёт преимущество, а удаление макрофагов устранит его.

Adds a controlled comparison of delayed TRPV4 suppression with IL-31 blockade and tests that localize the advantage to macrophage TRPV4.

A step in the mechanism

HERETICAL — In chronologically aged skin undergoing repeated minor repair, reduced is partly an adaptive restriction on killing recovery-competent tissue cells, rather than an exclusively pathological corpse-clearance defect.

Explicitly interprets reduced TIM-4 as a partly protective adaptation; the earlier record describes faulty discrimination after restoration without assigning this protective role to the deficiency.

A step in the mechanism

Stressed basal progenitors and repair fibroblasts can transiently display together with a second permissive eat-me signal, such as surface calreticulin, before irreversible death.

Adds a required permissive target signal, exemplified by calreticulin, beyond the earlier phosphatidylserine exposure mechanism.

A step in the mechanism

Slow corpse digestion extends the period during which highly phagocytic remain in the repair niche; the lasting damaging substrate is the resulting loss of functional tissue cells, rather than the undigested material itself.

Adds slow digestion as a timing amplifier of macrophage residence and explicitly separates it from the enduring damage substrate.

A sharper prediction

In contrast, increasing DNASE2A/protease activity to achieve verified final disposal should fail to restore function if -cell killing has already occurred. A proposed decisive effect is a greater than 20% loss of recoverable lineage output after rescue, with at least half of that incremental loss prevented by -target protection at matched corpse uptake within a prespecified 10% equivalence margin.

Adds a digestion-completion intervention as a discriminating negative rescue and numerical prospective thresholds for functional loss, protection, and corpse-uptake equivalence; these are proposed experimental thresholds, not established physiological cutoffs.

A way to test it

PS positivity alone must never be used to declare a cell either dead or destined for : Segawa, Suzuki and Nagata (2011), PNAS, DOI 10.1073/pnas.1114799108, PMID 22084121, https://pmc.ncbi.nlm.nih.gov/articles/PMC3228483/, showed that PS-exposing lymphoma cells were not engulfed. The hypothesis therefore requires the additional permissive target signal and direct fate evidence.

Imports a concrete counterexample to phosphatidylserine sufficiency, supporting the added permissive-signal requirement rather than merely repeating the earlier demand for subsequent target survival.

A step in the mechanism

Target-cell-restricted lysosomal repair could outperform attachment restoration through timely prevention of ingestion-dependent death, provided lysosomal dysfunction creates a reversible recognition or recovery state that repair changes before irreversible commitment.

Introduces lysosomal dysfunction as an upstream intervention point for preventing ingestion-dependent death.

A step in the mechanism

Dominance of gross functional-cell loss, net after replacement, and deterioration of tissue function are separate claims because replacement and compensation can modify the consequences of cell loss.

Explicitly distinguishes ingestion-driven cell loss from net depletion and functional deterioration after compensation.

A sharper prediction

Define dominance prospectively over a specified population and interval, for example as more than half of gross continuing functional-cell loss attributable to ingestion; this is an operational proposal, not an observed biological threshold. Report that attribution separately from net functional loss and account for interacting causes rather than summing overlapping losses.

Adds a quantitative test of the stronger claim that ingestion dominates ongoing functional-cell loss.

A sharper prediction

Validate precontact fate indicators in randomized matched protected cohorts; the same ingested cell's counterfactual recovery cannot be observed.

Adds a specific method for validating recoverability while addressing the unobservable fate of an ingested cell.

A sharper prediction

Target-only, conditioned-medium and secretion measurements must test whether apparent protection instead follows reduced initial injury or altered output.

Adds controls that distinguish ingestion-mediated protection from primary-injury prevention and secreted effects.

A sharper prediction

Test the contextual p38– link separately through p38 activity, surface abundance, attachment and internalization, with selective perturbation and interruption or rescue. MerTK effects cannot establish this link.

Introduces a separately testable upstream p38–TIM-4 link and specifies receptor-specific evidence.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

In , restoration increases of , before irreversible death. suppression of reversible exposure prevents this loss and restores repeated-challenge while labelled - clearance remains unchanged. Protected must subsequently survive and contribute ; negative alone are insufficient. Absence of rescuable live-cell , particularly if instead prevent recurrence, rejects this mechanism.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable changes in engulfment, sealing, clearance and subsequent cell fate, plus an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

, , , manipulation, and are available. A selective intervention requires validation that it neither directly improves nor prevents genuine -cell disposal.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

In , restoration increases of , before irreversible death. suppression of reversible exposure prevents this loss and restores repeated-challenge while labelled - clearance remains unchanged. Protected must subsequently survive and contribute ; negative alone are insufficient. Absence of rescuable live-cell , particularly if instead prevent recurrence, rejects this mechanism.

  • What would separate them

    Spatial inflammatory signals sustain recurring damage in aged skin despite restored clearance predicts: After spatially uniform mild challenge and verified clearance normalization, emerge at a reproducible nonzero . Independently measured predict that frequency and its change when distribution is altered. Spatially equalizing while matching their mean concentrations suppresses recurrence; the corresponding remains stable. Failure to demonstrate plus growth of a rejects this , even if improves recovery.

  • What would separate them

    Collagen fragments keep skin inflammation active after normal corpse clearance returns predicts: In a with normalized , production precedes recurrent and damage. Selective or suppresses recurrence, and measured-concentration restores it. Activity remains demonstrable in a well-mixed lacking , unlike the proposed . Failure of to control recurrence rejects this relay even if broad helps.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

In , inhibiting prevented inflammatory despite prior exposure, demonstrating that can execute death rather than merely follow it. This is an empirical precedent, not evidence that the proposed skin mechanism occurs. [Neher et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21402900/). The contrasting human anchor is improvement after and recovery. [De Maeyer et al., 2020](https://www.nature.com/articles/s41590-020-0646-0).

Subfield revised

: the textbook chapter 'Inflammation and Repair', specifically the therapeutic assumption that restoring necessarily supports repair. The proposed revision makes indispensable because normalized clearance can itself cause recurrent barrier injury.

Testable surprise

Increasing restores corpse disposal yet worsens cumulative barrier recovery; protecting living from reverses that deterioration without reducing .

Why this is not the mainstream account

Targeted searches did not identify a review or perspective proposing restoration as a cause of recoverable basal- elimination during repeated challenges in aged skin. itself is established elsewhere; novelty is this specific causal reversal in . Literature absence cannot be proven exhaustively, so heretical status remains provisional.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

1 paper retrieved around this hypothesis
  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>.PMID 33634751 · full_text · 322,070 characters stored

0 citation handles extracted; 1 Europe PMC search run; 1 records examined; 1 sources stored for enrichment, 1 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.